ST凯利（SZ 300326，收盘价：6.14元）8月20日晚间发布公告称，公司于2025年7月16日披露了涌金投 资送达的《上海凯利泰医疗科技股份有限公司要约收购报告书》。截至2025年8月15日，本次要约收购 期限届满。根据中国证券登记结算有限责任公司深圳分公司提供的数据统计，在2025年7月17日至2025 年8月15日要约收购期限内，最终有26个账户，共计约8.33万股股份接受收购人发出的要约，收购人收 购全部预受要约的股份。现要约收购结果已确认，经申请，公司股票将于2025年8月21日（星期四）上 午开市起复牌。 2024年1至12月份，ST凯利的营业收入构成为：医疗器械制造业占比56.82%，器械消毒服务业占比 26.48%，医疗器械贸易占比14.48%，其他业务占比2.21%。 （文章来源：每日经济新闻） ...

Core Points - ST Kelly announced that during the tender offer period from July 17 to August 15, 2025, a total of 26 accounts accepted the offer from Yongjin Investment Holding Co., Ltd, amounting to 83,297 shares [1] - The total shares accepted did not exceed the planned acquisition of 71,701,300 shares, and Yongjin Investment will fully acquire the shares tendered under the offer conditions [1] - Following the completion of the tender offer, Yongjin Investment will hold 50,183,300 shares of the company, representing 6.9989% of the total share capital [1] - The company's stock will resume trading on August 21 [1]

公司将于2025年8月21日(星期四)上午开市起复牌。 格隆汇8月20日丨ST凯利(300326.SZ)公布，在2025年7月17日至2025年8月15日要约收购期限内，最终有 26个账户，共计83,297股股份接受收购人涌金投资控股有限公司(简称"涌金投资"或"收购人")发出的要 约，未超过预定收购的股份数量71,701,268股，收购人将依据要约收购约定的条件全部收购预受要约的 股份。 本次要约收购完成后，涌金投资持有公司50,183,297股股份，占公司总股本的6.9989%。本次要约收购 不以终止上市公司上市地位为目的，本次要约收购后上市公司的股权分布将仍然符合深圳证券交易所规 定的上市条件。 ...

Group 1 - The core point of the article is that ST Kelly (300326.SZ) announced the completion of a tender offer by Yongjin Investment Holding Co., Ltd., where 26 accounts accepted the offer for a total of 83,297 shares, which is less than the targeted acquisition of 71,701,268 shares [1] - Following the tender offer, Yongjin Investment will hold 50,183,297 shares of the company, representing 6.9989% of the total share capital [1] - The tender offer is not aimed at terminating the company's listing status, and the share distribution will still comply with the listing conditions set by the Shenzhen Stock Exchange after the acquisition [1] Group 2 - The resumption of trading for the company is scheduled for August 21, 2025, at the market opening [1]

Group 1 - The company ST Kaili announced that the offer period for its share buyback has expired, with a total of 83,297 shares accepted from 26 accounts, which did not meet the target buyback amount of 71.7 million shares [1] - Following the completion of the buyback, Yongjin Investment will hold 50.18 million shares, representing 6.9989% of the company's total share capital [1] - The buyback is not intended to terminate the company's listing status, and the share distribution post-buyback still complies with the Shenzhen Stock Exchange listing requirements [1]

证券代码：300326 证券简称：ST 凯利 公告编号：2025-082 一、本次要约收购的基本情况 1.收购人：涌金投资控股有限公司 上海凯利泰医疗科技股份有限公司 关于涌金投资控股有限公司要约收购 结果暨股票复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1.上海凯利泰医疗科技股份有限公司（以下简称"公司"或"上市公司"， 股票简称：ST凯利，股票代码：300326）将于2025年8月21日（星期四）上午开 市起复牌。 2.在2025年7月17日至2025年8月15日要约收购期限内，最终有26个账户，共 计83,297股股份接受收购人涌金投资控股有限公司（以下简称"涌金投资"或"收 购人"）发出的要约，未超过预定收购的股份数量71,701,268股，收购人将依据 要约收购约定的条件全部收购预受要约的股份。 3.本次要约收购完成后，涌金投资持有公司50,183,297股股份，占公司总股 本的6.9989%。本次要约收购不以终止上市公司上市地位为目的，本次要约收购 后上市公司的股权分布将仍然符合深圳证券交易所规定的上市条件。 公司于20 ...

Core Points - ST Kelly announced that from July 17, 2025, to August 15, 2025, a total of 26 accounts accepted the tender offer from Yongjin Investment, amounting to 83,297 shares, which did not exceed the planned acquisition of 71.7013 million shares [1] - Following the completion of the tender offer, Yongjin Investment will hold 50.1833 million shares of the company, representing 6.9989% of the total share capital [1]

Core Points - The announcement details the completion of the tender offer by Yongjin Investment Holdings for Shanghai Kelly Tai Medical Technology Co., Ltd. [1] - The tender offer price is set at 5.18 CNY per share, targeting 71,701,268 shares, which represents 10% of the company's total share capital [1] - The tender offer period lasted for 30 calendar days, starting from the announcement date until August 15, 2025 [1] Company Actions - The company has applied for a trading suspension of its shares on the Shenzhen Stock Exchange, effective from August 18, 2025, until the announcement of the tender offer results [1] - The company will closely monitor the progress of the tender offer and fulfill its information disclosure obligations as per relevant laws and regulations [2]

Group 1 - ST凯利 announced a tender offer from Yongjin Investment for 71.70 million shares at a price of 5.18 yuan per share, representing 10% of the company's total equity [1] - The tender offer period ended on August 15, 2025, and the company has applied for a trading suspension starting August 18, 2025, pending confirmation of the offer results [1] - As of the announcement, ST凯利's revenue composition for 2024 is as follows: 56.82% from medical device manufacturing, 26.48% from instrument disinfection services, 14.48% from medical device trading, and 2.21% from other businesses [1] Group 2 - The current market capitalization of ST凯利 is 4.4 billion yuan [2]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 上海凯利泰医疗科技股份有限公司（以下简称"公司"）于2025年7月16日 披露了涌金投资控股有限公司（以下简称"涌金投资"）送达的《上海凯利泰医 疗科技股份有限公司要约收购报告书》，涌金投资向除涌金投资以外的公司全体 持有无限售条件流通股（不包括公司回购专用证券账户持有的13,651股股份，下 同，截至本公告日，该部分回购股份已注销）的股东发出的部分要约收购（以下 简称"本次要约收购"），要约价格为5.18元/股，要约收购股份数量71,701,268 股，占公司总股本的10%。本次要约收购期限共计30个自然日，要约起始日期是 2025年7月17日，要约截止日期是2025年8月15日。 证券代码：300326 证券简称：ST 凯利 公告编号：2025-081 上海凯利泰医疗科技股份有限公司 关于涌金投资控股有限公司要约收购 期限届满暨股票停牌的公告 1 董事会 二○二五年八月十五日 2 截至2025年8月15日，本次要约收购期限已届满。鉴于本次要约收购结果需 进一步确认，根据《深圳证券交易所创业板股票上市规则》《深 ...